Supplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Chun-Miao Deng,Guo-Geng Zhang,Qin-Wen Liu,Jiao-Jiao Xu,Zhi-Chao Liu,Jing Yang,Tao-Yang Xu,Zhi-Gang Li,Fan Zhang,Bin Li

DOI: https://doi.org/10.1158/0008-5472.22929962.v1

2023-01-01

Abstract:Supplementary Table 6 shows DEGs of EC9706 overexpressing ANO1 and control cells

What problem does this paper attempt to address?

Supplementary Table 7 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Chun-Miao Deng,Guo-Geng Zhang,Qin-Wen Liu,Jiao-Jiao Xu,Zhi-Chao Liu,Jing Yang,Tao-Yang Xu,Zhi-Gang Li,Fan Zhang,Bin Li

DOI: https://doi.org/10.1158/0008-5472.22929959

2023-01-01

Abstract:Supplementary Table 7 shows Human transcription factor in ANO1 interacting proteins detected by IP-MS
Supplementary Table 5 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Chun-Miao Deng,Guo-Geng Zhang,Qin-Wen Liu,Jiao-Jiao Xu,Zhi-Chao Liu,Jing Yang,Tao-Yang Xu,Zhi-Gang Li,Fan Zhang,Bin Li

DOI: https://doi.org/10.1158/0008-5472.23283285.v1

2023-01-01

Abstract:Supplementary Table 5 shows Correlation between ANO1 expression levels and clinicopathological parameters in 100 cases of esophageal cancer
Supplementary Figure from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Chun-Miao Deng,Guo-Geng Zhang,Qin-Wen Liu,Jiao-Jiao Xu,Zhi-Chao Liu,Jing Yang,Tao-Yang Xu,Zhi-Gang Li,Fan Zhang,Bin Li

DOI: https://doi.org/10.1158/0008-5472.23283270

2023-01-01

Abstract:Supplementary figures shows Supplementary figures and figure legends
ANO1 reprograms cholesterol metabolism and the tumor microenvironment to promote cancer metastasis

Chun-Miao Deng,Guo-Geng Zhang,Qin-Wen Liu,Jiao-Jiao Xu,Zhi-Chao Liu,Jing Yang,Tao-Yang Xu,Zhi-Gang Li,Fan Zhang,Bin Li

DOI: https://doi.org/10.1158/0008-5472.can-22-3490

IF: 11.2

2023-03-15

Cancer Research

Abstract:Tumor metastasis is a complex process. A better understanding of the mechanistic underpinnings of the metastatic cascade could uncover approaches to better prevent and target metastases. Here, we integrated transcriptomic profiling in primary esophageal squamous cell carcinoma (ESCC) and matched lymph node metastatic tissues and genome-wide CRISPR/Cas9 functional screening to identify the key drivers of cancer metastasis. Anoctamin 1 (ANO1) expression was found to be elevated in primary tumors and further increased in metastatic tissues. High expression of ANO1 was associated with poor patient survival, and ANO1 overexpression promoted cancer invasion and metastasis. Mechanistically, ANO1 inactivated the LXR pathway and increased intracellular cholesterol accumulation by interacting with JUN to repress the transcription of cholesterol hydroxylase, CYP27A1. In a paracrine manner, interleukin 1β (IL-1β) secreted from ANO1-expressing ESCC cancer cells activated NFκB signaling in fibroblasts to stimulate production of the chemokine CCL1, which in turn enhanced invasion of ESCC cancer cells. Furthermore, molecular docking and in silico screening of 1,500,000 small molecules identified K786-4469 as a lead compound that targeted ANO1 and suppressed cancer metastasis in vitro and in vivo. Overall, these findings uncover a non-canonical function of ANO1 in regulating cholesterol metabolism and fibroblast function, revealing ANO1 as a potential prognostic biomarker and therapeutic target for metastatic ESCC.

oncology
Figure S6 from Consistent and Differential Genetic Aberrations between Esophageal Dysplasia and Squamous Cell Carcinoma Detected By Array Comparative Genomic Hybridization

Zhi-Zhou Shi,Li Shang,Yan-Yi Jiang,Jia-Jie Hao,Yu Zhang,Tong-Tong Zhang,De-Chen Lin,Shu-Guang Liu,Bo-Shi Wang,Ting Gong,Qi-Min Zhan,Ming-Rong Wang

DOI: https://doi.org/10.1158/1078-0432.22450374

2023-01-01

Abstract:Effect of ANO1 on cell proliferation. Knock-down the expression of ANO1 inhibited the cell proliferation of KYSE30 (A) and KYSE510 cells (B). The absorbance at 450 nm was measured.
Supplementary Table 1 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER+ Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Yan Lü,Ming You,Zara Ghazoui,Pengyuan Liu,Peter T. Vedell,Wen Wang,Ann M. Bode,Clinton J. Grubbs,Ronald A. Lubet

DOI: https://doi.org/10.1158/1940-6207.22524285

2023-01-01

Abstract:XLSX file - 87K, Gene Expression Changes Comparing Control Rat Tumors and Rat Tumors Treated with Vorozole
Supplementary Table 2 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER+ Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Yan Lu,Ming You,Zara Ghazoui,Pengyuan Liu,Peter T. Vedell,Weidong Wen,Ann M. Bode,Clinton J. Grubbs,Ronald A. Lubet

DOI: https://doi.org/10.1158/1940-6207.22524282

2023-01-01

Abstract:XLSX file - 244K, Gene Expression Changes Comparing Control Breast Cancers and Letrozole Treated Breast Cancer in Humans (GSE 5462)
High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer

Guangnian Zhang,Zhihui Shu,Jun Yu,Jianshui Li,Pengsheng Yi,Bin Wu,Dawei Deng,Shu Yan,Yong Li,Dongmei Ren,Yifu Hou,Chuan Lan

DOI: https://doi.org/10.3389/fimmu.2024.1341209

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:Background: Aminooctylamine (ANO1) plays an oncogenic role in various cancers. However. its role in pancreatic cancer (PC) has rarely been studied. This study investigated the prognostic value of ANO1 and its correlation with the tumor microenvironment (TME) in PC. Methods: Consecutive patients with PC (n = 119) were enrolled. The expression of ANO1 in cancer cells, the expression of fibroblast activation protein (FAP) and alpha smooth muscle actin in cancer-associated fibroblasts (CAFs), and the numbers of CD8- and FOXP3-positive tumor-infiltrating lymphocytes (TILs) were evaluated using immunohistochemistry. The prognostic value of ANO1 and its correlation with CAF subgroups and TILs were analyzed. The possible mechanism of ANO1 in the TME of PC was predicted using the the Cancer Genome Atlas (TCGA) dataset. Results: The expression of AN01 was correlated with overall survival (OS) and disease-free survival. Multi-factor analysis showed that high ANO1 expression was an independent adverse prognostic factor for OS (hazard ratio, 4.137; P = 0.001). ANO1 expression was positively correlated with the expression of FAP in CAFs (P < 0.001) and negatively correlated with the number of CD8-positive TILs (P = 0.005), which was also validated by bioinformatics analysis in the TCGA dataset. Moreover, bioinformatic analysis of the TCGA dataset revealed that ANO1 may induce an immunosuppressive tumor microenvironment in pancreatic cancer in a paracrine manner. Conclusion: ANO1 is a prognostic factor in patients with PC after radical resection. ANO1 may induce an immunosuppressive tumor microenvironment in PC in a paracrine manner, suggesting that ANO1 may be a novel therapeutic target.

immunology
Supplementary Table from Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR Through APMAP

Siyuan Jiang,Xuetong Wang,Dalong Song,XiaoJun Liu,Yinmin Gu,Zhiyuan Xu,Xiaodong Wang,Xiaolu Zhang,Qinong Ye,Zhou Tong,BingXue Yan,Jie Yu,Yunzhao Chen,Minxuan Sun,Yang Wang,Shan Gao

DOI: https://doi.org/10.1158/0008-5472.22421076

2023-01-01

Abstract:Supplementary Table S1-S8, the first line of each table contains the description of the table.
Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419828

2023-01-01

Abstract:Supplementary Table S2. Patient characteristics
Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Binghao Li,Zhan Wang,Hao Wu,Mingfeng Xue,Peng Lin,Shengdong Wang,Nong Lin,Xin Huang,Weibo Pan,Meng Liu,Xiaobo Yan,Hao Qu,Lingling Sun,Hengyuan Li,Yan Wu,Wangsiyuan Teng,Zenan Wang,Xingzhi Zhou,Huabiao Chen,Mark C. Poznansky,Zhaoming Ye

DOI: https://doi.org/10.1158/0008-5472.22419831

2023-01-01

Abstract:Supplementary Table S1. Primers for qRT-PCR and MSP
ANO1‐Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer‐Associated Fibroblasts

Fangli Jiang,Keren Jia,Yang Chen,Congcong Ji,Xiaoyi Chong,Zhongwu Li,Feilong Zhao,Yuezong Bai,Sai Ge,Jing Gao,Xiaotian Zhang,Jian Li,Lin Shen,Cheng Zhang

DOI: https://doi.org/10.1002/advs.202300881

IF: 15.1

2023-06-22

Advanced Science

Abstract:This work highlights ANO1 as a promising target for gastrointestinal (GI) cancers' precision treatment. ANO1 is highly amplified or expressed in GI cancers. Through inhibiting cancer cell ferroptosis in a PI3K‐Akt‐dependent manner, ANO1 stimulates the production and secretion of TGF‐β by cancer cells, subsequently strengthens cancer‐associated fibroblast recruitment, and cripples CD8+ T cell‐mediated anti‐tumor immune responses, generating resistance to immunotherapy. The application of immunotherapy in gastrointestinal (GI) cancers remains challenging because of the limited response rate and emerging therapeutic resistance. Combining clinical cohorts, multi‐omics study, and functional/molecular experiments, it is found that ANO1 amplification or high‐expression predicts poor outcomes and resistance to immunotherapy for GI cancer patients. Knocking‐down or inhibiting ANO1 suppresses the growth/metastasis/invasion of multiple GI cancer cell lines, cell‐derived xenograft, and patient‐derived xenograft models. ANO1 contributes to an immune‐suppressive tumor microenvironment and induces acquired resistance to anti‐PD‐1 immunotherapy, while ANO1 knockdown or inhibition enhances immunotherapeutic effectiveness and overcomes resistance to immunotherapy. Mechanistically, through inhibiting cancer ferroptosis in a PI3K‐Akt signaling‐dependent manner, ANO1 enhances tumor progression and facilitates cancer‐associated fibroblast recruitment by promoting TGF‐β release, thus crippling CD8+ T cell‐mediated anti‐tumor immunity and generating resistance to immunotherapy. This work highlights ANO1's role in mediating tumor immune microenvironment remodeling and immunotherapeutic resistance, and introduces ANO1 as a promising target for GI cancers' precision treatment.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Supplementary Table S9 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu‐Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229782.v1

2023-01-01

Abstract:Supplementary Table S9. DE miRNAs in C2 (High) compared with C1 (Low).
Supplementary Table 1 from Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma

Chunhua Lu,Tomas Bonome,Yang Li,Aparna A. Kamat,Liz Y. Han,Rosemarie Schmandt,Robert L. Coleman,David M. Gershenson,Robert B. Jaffe,Michael J. Birrer,Anil K. Sood

DOI: https://doi.org/10.1158/0008-5472.22370993.v1

2023-01-01

Abstract:Supplementary Table 1 from Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma
Supplementary Tables from DNMT1–MicroRNA126 Epigenetic Circuit Contributes to Esophageal Squamous Cell Carcinoma Growth Via ADAM9–EGFR–AKT Signaling

Ronghua Liu,Jie Gu,Pei Jiang,Yijie Zheng,Xiaoming Liu,Xuechao Jiang,Enyu Huang,Shudao Xiong,Fengkai Xu,Guangwei Liu,Di Ge,Yiwei Chu

DOI: https://doi.org/10.1158/1078-0432.22460703

2023-01-01

Abstract:The file included six supplementary tables as following: Table S1.Clinicopathological Characteristics; Table S2. Differently expressed miRNAs between ECs and NMs; Table S3. Univariate and Multivariate analysis of factors associated with disease-specific survival; Table S4. A short list of functionally relevant genes significantly downredulated in 126-EC cells vs. NC-EC cells; Table S5. Primer sequences (5'-3'), Table S6. The primary antibodies for western blot and IHC.
Identification And Characterization Of Ano9 In Stage Ii And Iii Colorectal Carcinoma

Chunxiang Li,Sanjun Cai,Xishan Wang,Zheng Jiang

DOI: https://doi.org/10.18632/oncotarget.4979

2015-01-01

Oncotarget

Abstract:Background and Objectives: The precise role and potential underlying mechanisms of anoctamin 9 (ANO9) remain largely unknown. This study aims to characterize the role and oncogenic mechanisms of ANO9 in stage II and III colorectal cancer (CRC).Methods: We examined the expression of ANO9 in colorectal cancerous tissues and cells using real-time quantitative PCR and immunohistochemistry, respectively. Multiple cellular and molecular approaches such as gene transfection, CCK-8 assay, flow cytometry, and invasion assay were also performed to explore its oncogenic mechanisms. Furthermore, the clinical significance of ANO9 in clinical CRC specimens was assessed by clinical correlation and survival analyses.Results: Lower expression of ANO9 messenger RNA (mRNA) was frequently detected both in CRC tissues with recurrence and metastasis-derived cell lines. Compared with matched nontumorous tissues, lower expression of ANO9 protein was observed in tumors, which was significantly correlated with tumorigenesis (p < 0.05). In vitro functional studies showed that ANO9 contributed to tumor cell proliferation, apoptosis, and invasion. Moreover, investigation of clinical CRC specimens showed that ANO9 were markedly overexpressed in metastatic tissue compared with primary tissue. Decreased expression of ANO9 was correlated with poor prognostic outcomes.Conclusions: This study highlighted the role of ANO9 in progression and metastasis of stage II and III CRC. These findings suggested that up-regulation of ANO9, as a metastasis-related gene, could be a novel approach for inhibiting CRC progression.
Exploring the Diversified Roles of Anoctamin Family in Pan-Cancer

Yifan Liu,Bingnan Lu,Xuyang Jia,Yuntao Yao,Mingyu Qu,Tianyue Yang,Xu Song,Xiuwu Pan,Wang Zhou,Xingang Cui

DOI: https://doi.org/10.21203/rs.3.rs-3233965/v1

2023-01-01

Abstract:Abstract Background Anoctamin family (Transmembrane Protein 16), has gained growing attention for generating exosome and ectosome to mediate cancer cell communication in the process of phospholipid scrambling. However, former studies only focused on one narrow process in a single cancer. Instead, we designed a multidimensional study to comprehensively investigate the impact of ANO family on eight critical multi-omics cancer features in TCGA pan-cancer cohort. Methods TCGA pan-cancer cohorts were downloaded from UCSC xena. Differential analysis, survival analysis, and correlation analysis with tumor mutation burden, immune-phenotyping, stemness, cell proportion of tumor microenvironment, and drug sensitivity were conducted by R software. Alteration landscape was obtained from cBioportal with STRING database showing the protein-protein interaction network. Nanoparticle Tracking Analysis and Western Blot were employed to identify the ANO5 exosome. Results Extensive and profound associations were found between ANO family and eight crucial cancer features, including clinical prognosis, metastasis, drug resistance, tumor mutation burden, stemness, and tumor microenvironment. ANO1 possessed a high mutation frequency and is a driver gene in multiple cancers. ANO5 can exist in exosome to mediate cell-cell communication. Conclusions ANO family broadly participates in the proliferation, metastasis, and drug resistance in a barrage of cancers by generating extracellular vesicles to mediate cell-cell communication and interacting with TMB, stemness, stromal and immune cell proportions in tumor microenvironment. ANO members can serve as reliable biomarkers for prognosis of cancer, as well as promising targets for trans-cancer treatment.
Involvement of TMEM16A/ANO1 Upregulation in the Oncogenesis of Colorectal Cancer

Yufen Yan,Xiaoyan Ding,Chunhua Han,Jianjun Gao,Zongtao Liu,Yani Liu,KeWei Wang

DOI: https://doi.org/10.1016/j.bbadis.2022.166370

IF: 6.633

2022-01-01

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Abstract:The Ca2+-activated Cl− channel ANO1 is widely expressed in epithelial cells, and ANO1 upregulation is implicated in the oncogenesis of many epithelium-originated cancers. However, whether ANO1 plays a causal role in the tumorigenesis of colorectal cancer remains largely unknown. Here, we show that ANO1 channel protein is upregulated in human colorectal cancer tissue samples and its upregulation is correlated with the TNM staging, histological type, pathological differentiation and poor prognosis. Knockdown or pharmacological inhibition of ANO1 suppresses colorectal cancer cell proliferation and induces cell apoptosis. Furthermore, ANO1 knockdown inhibits the growth of subcutaneous xenograft tumors implanted with colorectal cancer HT-29 cells in nude mice. Mechanically, knockdown of endogenous ANO1 inactivates the Wnt/β-catenin signaling through downregulating critical components, such as Frizzled protein 1, β-catenin and upregulating GSK3β. Taken together, our results demonstrate that ANO1 upregulation is involved in the tumorigenesis of colorectal cancer, and inhibition of ANO1 upregulation or inactivating downstream Wnt/β-catenin signaling may have therapeutic potential for colorectal cancer.
Supplementary Tables from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

Tao Yu,Yingjun Zhao,Zhixiang Hu,Jing Li,Dandan Chu,Jiwei Zhang,Zhe Li,Bing Chen,Xiao Zhang,Hongyu Pan,Shengli Li,Hechun Lin,Lei Liu,Mingxia Yan,Xianghuo He,Ming Yao

DOI: https://doi.org/10.1158/0008-5472.22418429.v1

2023-01-01

Abstract:Several tables contain the nucleotide sequences, antibodies information, LncRNA expression profiles, LncRNA screening, the correlation between MetaLnc9 and clinicopathological features, the mass spectrometric analysis results, RNA-seq analysis, KEGG and GSEA analysis.
Supplementary Table S5 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu-Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229797.v1

2023-01-01

Abstract:Supplementary Table S5. DE genes in C2 (High) compared with C3 (Moderate).

Supplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Supplementary Table 7 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Supplementary Table 5 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Supplementary Figure from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

ANO1 reprograms cholesterol metabolism and the tumor microenvironment to promote cancer metastasis

Figure S6 from Consistent and Differential Genetic Aberrations between Esophageal Dysplasia and Squamous Cell Carcinoma Detected By Array Comparative Genomic Hybridization

Supplementary Table 1 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER<sup>+</sup> Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Supplementary Table 2 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER<sup>+</sup> Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer

Supplementary Table from Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR Through APMAP

Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

ANO1‐Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer‐Associated Fibroblasts

Supplementary Table S9 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Supplementary Table 1 from Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma

Supplementary Tables from DNMT1–MicroRNA126 Epigenetic Circuit Contributes to Esophageal Squamous Cell Carcinoma Growth Via ADAM9–EGFR–AKT Signaling

Identification And Characterization Of Ano9 In Stage Ii And Iii Colorectal Carcinoma

Exploring the Diversified Roles of Anoctamin Family in Pan-Cancer

Involvement of TMEM16A/ANO1 Upregulation in the Oncogenesis of Colorectal Cancer

Supplementary Tables from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

Supplementary Table S5 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

Supplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Supplementary Table 7 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Supplementary Table 5 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

Supplementary Figure from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis

ANO1 reprograms cholesterol metabolism and the tumor microenvironment to promote cancer metastasis

Figure S6 from Consistent and Differential Genetic Aberrations between Esophageal Dysplasia and Squamous Cell Carcinoma Detected By Array Comparative Genomic Hybridization

Supplementary Table 1 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER&lt;sup&gt;+&lt;/sup&gt; Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Supplementary Table 2 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER&lt;sup&gt;+&lt;/sup&gt; Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer

Supplementary Table from Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR Through APMAP

Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

ANO1‐Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer‐Associated Fibroblasts

Supplementary Table S9 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Supplementary Table 1 from Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma

Supplementary Tables from DNMT1–MicroRNA126 Epigenetic Circuit Contributes to Esophageal Squamous Cell Carcinoma Growth Via ADAM9–EGFR–AKT Signaling

Identification And Characterization Of Ano9 In Stage Ii And Iii Colorectal Carcinoma

Exploring the Diversified Roles of Anoctamin Family in Pan-Cancer

Involvement of TMEM16A/ANO1 Upregulation in the Oncogenesis of Colorectal Cancer

Supplementary Tables from MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

Supplementary Table S5 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

Supplementary Table 1 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER<sup>+</sup> Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes

Supplementary Table 2 from Concordant Effects of Aromatase Inhibitors on Gene Expression in ER<sup>+</sup> Rat and Human Mammary Cancers and Modulation of the Proteins Coded by These Genes